檢索結果 - Catalin Doru DANAILA

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options 由 Jean‐Jacques Kiladjian, Francisca Ferrer‐Marín, Haifa Kathrin Al‐Ali, Alberto Álvarez‐Larrán, Eloise Beggiato, Maria Bieniaszewska, Massimo Breccia, Veronika Buxhofer‐Ausch, O Cerná, Ana-Manuela Crisan, Catalin Doru DANAILA, Valerio De Stefano, Konstanze Döhner, Victoria Empson, Joanna Góra‐Tybor, Martin Grießhammer, Sebastian Grosicki, Paola Guglielmelli, Valentín García‐Gutiérrez, Florian H. Heidel, Árpád Illés, Ciprian Tomuleasa, Chloé James, Steffen Koschmieder, Maria‐Theresa Krauth, Kurt Krejcy, M. Lazaroiu, Jiřı́ Mayer, Zsolt György Nagy, Franck‐Emmanuel Nicolini, Francesca Palandri, Vassiliki Pappa, Andreas Reiter, Tomasz Sacha, Stefanie Schlager, Stefan Schmidt, Evangelos Terpos, Martin Unger, Albert Wölfler, Blanca Xicoy Cirici, Christoph Klade